Artificial Intelligence

Google tackles AI’s biggest challenge: Under its Everyday Robots subsidiary, the tech giant is building bots that understand what humans really want. But internet data could steer the project off-course.

Amazon is acquiring Roomba vacuum maker iRobot, adding yet another connected device to its offerings.

Digital startups to watch this week: We spotlight funding rounds from predictive analytics platform Biofourmis, AI medical documentation company Abridge, and virtual health clinic Salvo Health.

Amazon’s Roomba acquisition is a data privacy nightmare: Regulators are worried that Amazon, which already has eyes and ears in consumers’ homes, will now be able to map and monitor those homes.

On today's episode, we discuss why Spotify is cautiously optimistic, the potential of video podcasts, and whether TikTok Music could be the next big podcast app. "In Other News," we talk about why people buy smart speakers and how crucial gaming is for Netflix's future. Tune in to the discussion with our analyst Daniel Konstantinovic and senior account director Michael Civins.

Computing falls back to earth: The cloud is growing, but some companies are migrating away to cut costs on AI training. More complex applications require a bigger toolbag of solutions.

Big Tech earnings buoyed by cloud: Microsoft and Alphabet’s quarterly earnings weren’t as bad as expected, boosting market confidence. But continued strength hinges on cloud divisions that aren’t recession-proof.

Seedtag nets $250 million to solve the post-cookie future: The company will set its sights on North American expansion.

AI reads the operating room: Surgeries may soon be under AI surveillance as startup Theator expands its video analytics to operating rooms. It could yield helpful insights as well as controversy.

Health systems huddle up on predictive medicine: We detail why large health systems like Mayo Clinic and Mercy are collaborating to advance disease detection.

Cadence enters the life science market to revolutionize drug discovery: Its OpenEye Scientific acquisition is an example of pharma’s investment in biosimulations for therapeutic research.

Gaming segment stutters: Inflation, shortages, and price increases have all contributed to a decline in YoY spending on video games, hardware, content, and accessories. Can the gaming industry rebound in 2022?

AI applications are becoming more common across functions including supply chain, product, and back office. Brands are using AI tools to generate deep customer insights, track supplier pricing, and more.

AI to help train drones: Microsoft’s Project AirSim combines its expertise in AI, flight simulators, cloud computing, and military-grade security to develop the next generation of drones.

AI startups target corporate fear: Mounting recession anxiety is infusing accounting AI startups with cash. Long-term investor interest in AI applications will remain diverse, but startups may have to pivot.

NIkon to end DSLR line: Smartphones have an opportunity to seize the camera market, but smaller bodies and lack of long lenses will be tough to overcome. Computational photography could help fill the gaps.

AI catches diabetes that would otherwise go undetected: Using a single retinal image from each eye, the tech can diagnose diabetes at far earlier stages than human doctors.